Gastroenterology & Nutrition | Parenteral Nutrition
TPN Constituents
Glucose provides the major energy source of parenteral nutrition.
Although any concentration of glucose may be selected, certain
concentrations provide for easier calculations and sufficient
calories when employed with common infusion rates. Glucose provides
4 kcal/gm. Strictly speaking, glucose in PN solutions is hydrated
and thus provides only 3.4 kcal/gm of actual hydrated weight. To
simplify calculations, however, glucose is commonly estimated to
provide its actual 4 kcal/gm. Thus, a 10% glucose or dexstrose
solution supplies 40 kcal/100ml or 0.4 kcal/ml. A 20% glucose
solution provides 0.8 kcal/ml.
For PN solutions infused via peripheral vein, glucose concentration
should not exceed 12.5%. Higher concentrations of glucose produce PN
solutions of sufficiently high osmolarity that venous endothelium
may be damaged, resulting in venous thrombosis and sclerosis.
For PN solutions infused via central vein, the high venous flow rate
rapidly dissipates the high osmolarity. Although a 20% glucose
concentration is standard, concentrations as high as 40% can be
employed if required by fluid restrictions.
Cyrstalline amino acids provide the building blocks for protein in
PN. Standard commercially produced mixtures of essential and
non-essential amino acids are available for compounding PN.
Trophamine and Travasol are the two formulations most commonly
employed at SLCH. Trophamine was designed for term and premature
infants up to age 3 months. Trophamine infusion replicates the serum
amino acid concentrations of a breast-fed infant. Travasol was
designed for adults, but experience indicates that it meets the
nutritional needs of children. Specialized formulations have been
designed for patients with renal and hepatic disease, but evidence
is lacking to demonstrate that these mixtures are more efficacious
in those disorders.
| |
Trophamine 1.6% |
Travasol 1.6% |
Essential Amino Acids
|
| Isoleucine |
131 | 76 |
| Leucine |
224 | 100 |
| Valine |
125 | 73 |
| Threonine |
67 | 67 |
| Methionine |
53 | 93 |
| Tryptophan |
32 | 29 |
| Phenylalanine |
77 | 100 |
| Lysine |
131 | 93 |
Semi-Essential Amino Acids
|
| Histidine |
77 | 70 |
| Tyrosine |
37 | 6 |
| Cysteine |
65 added | 0 |
| Taurine |
4 | 0 |
Non-Essential Amino Acids
|
| Glycine |
59 | 331 |
| Alanine |
85 | 331 |
| Proline |
109 | 67 |
| Serine |
61 | 0 |
| Arginine |
195 | 166 |
| Aspartate |
51 | 0 |
| Glutamine |
80 | 0 |
Preparation:
MVI-Pediatric (5 ml)
|
MVI-Adult (10 ml)
|
|
|
Ascorbic acid
|
80 mg | 200 mg |
|---|
|
Vitamin A
|
0.7 mg | 1.0 mg |
|---|
|
Vitamin D
|
10 mcg | 5 mcg |
|---|
|
Thiamine
|
1.2 mg | 6.0 mg |
|---|
|
Riboflavin
|
2.0 mg | 3.6 mg |
|---|
|
Pyridoxine
|
1.0 mg | 6.0 mg |
|---|
|
Niacinamide
|
17 mg | 40 mg |
|---|
|
Dexapanthenol
|
5.0 mg | 15 mg |
|---|
|
Vitamin E
|
7.0 mg | 10 mg |
|---|
|
Biotin
|
20 mcg | 60 mcg |
|---|
|
Folic acid
|
140 mcg | 600 mcg |
|---|
|
Vitamin B12
|
1 mcg | 5 mcg |
|---|
|
Vitamin K
|
200 mcg | 150 mcg |
The exact amount of MVI-Ped added to a PN solution depends on the
patient's weight.
| | Daily MVI-Ped Dose |
|
Weight ≤ 1.5 kg
|
1.5 ml
|
Weight between
1.5 kg and 3 kg
|
3.25 ml
|
|
Weight > 3 kg
|
5 ml
|
| |
TMA mixture
and volume
|
Constituents
|
|
Weight ≤ 3 kg
|
Premature Trace
Element Mixture
(0.2 ml/kg/day)
|
- Zinc 300 mcg/day
- Manganese 5 mcg/kg/day
- Copper 20 mcg/kg/day
- Chromium 0.17 mcg/kg/day
|
Weight between
3 kg and 20 kg
|
Pediatric Trace
Element Mixture
(0.2 ml/kg/day)
|
- Zinc 200 mcg/kg/day
- Manganese 5 mcg/kg/day
- Copper 20 mcg/kg/day
- Chromium 0.2 mcg/kg/day
|
|
Weight > 20 kg
|
Trace Metal
Additive
(5 ml/day)
|
- Zinc 4 mg/day
- Manganese 0.8 mg/day
- Copper 1 mg/day
- Chromium 10 mcg/day
|
Intravenous lipid provides essential fatty acids and supplemental
calories. Intralipid is the standard commercial form of intravenous
lipid.
Intralipid Constituents
|
Concentration
|
20%
| |
|
Water
|
76.5%
| |
|
*Soy Oil
|
20%
|
*
Soy Oil contains
44 to 62% linoleic acid,
4 to 11% linolenic acid,
19 to 30% oleic acid,
7 to 14% palmitic acid,
and 1.4 to 5.5% stearic acid.
|
|
Phospholipid
|
1.2%
| |
|
Glycerol
|
2.25%
| |
|
kcal/ml
|
2.0
| |
|
mOsm/L
|
260
| |
| Solution |
Osmolarity |
Infusion Site
|
|
| D20-AAM16 |
1600 mOsm/L |
Central
|
| D20-AAM30 |
1800 mOsm/L |
Central
|
| D10-AAM16 |
1000 mOsm/L |
Peripheral or Central
|
| D10-AAM30 |
1100 mOsm/L |
Peripheral or Central
|
| 20% Intralipid |
260 mOsm/L |
Peripheral or Central
|
|